Ovarian function suppression: To what extent is it necessary for premenopausal patients with operable hormone-sensitive breast cancer?
The use of tamoxifen is conventional adjuvant hormone therapy in premenopausal patients with receptor-positive breast cancer. Clinical trials demonstrating the benefits of ovarian function suppression as adjuvant treatment had an ambiguous interpretation. There is no scientific evidence favoring the...
| 主要作者: | |
|---|---|
| 格式: | 文件 |
| 语言: | Russian |
| 出版: |
ABV-press
2015-09-01
|
| 丛编: | Опухоли женской репродуктивной системы |
| 主题: | |
| 在线阅读: | https://ojrs.abvpress.ru/ojrs/article/view/446 |